Two frequently altered pathways in colon cancer, TGFβ/SMAD and WNT/β-catenin, have been shown to possess clusters of regulatory sites in promoters of claudins 1 to 7 and occludin. The gene discussed is CLDN1; the disease is malignant colon neoplasm.